CTNNB1 and liver cancer: The liver-cancer-specific signature 16 [21] was significantly higher in samples with MMs in CTNNB1 than samples with the wild-type CTNNB1, although no significant differences in the signature score between samples with SM in CTNNB1 and samples with the wild-type CTNNB1 (Fig. 2d).